Pacer Advisors, Inc. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 369 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Pacer Advisors, Inc. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1,541,793
+35.8%
29,446
+5.5%
0.00%0.0%
Q1 2024$1,135,623
+16.5%
27,916
+5.8%
0.00%0.0%
Q4 2023$974,857
+129.6%
26,376
+137.3%
0.00%
+50.0%
Q3 2023$424,593
-64.7%
11,115
-66.7%
0.00%
-60.0%
Q2 2023$1,204,017
+279.8%
33,380
+302.2%
0.01%
+400.0%
Q1 2023$316,977
-78.5%
8,300
-68.0%
0.00%
-87.5%
Q4 2022$1,474,620
+532.9%
25,916
+339.6%
0.01%
+300.0%
Q3 2022$233,000
-61.2%
5,895
-60.5%
0.00%
-66.7%
Q4 2021$600,000
-24.5%
14,912
-23.7%
0.01%
-40.0%
Q3 2021$795,000
+26.2%
19,552
+40.8%
0.01%
+11.1%
Q2 2021$630,000
-4.0%
13,884
-11.8%
0.01%
-18.2%
Q1 2021$656,000
+32.8%
15,743
+36.0%
0.01%
+22.2%
Q4 2020$494,000
+308.3%
11,578
+151.4%
0.01%
+200.0%
Q3 2020$121,000
-1.6%
4,606
-31.9%
0.00%
-40.0%
Q3 2018$123,000
+186.0%
6,765
+218.4%
0.01%
+66.7%
Q4 2017$43,0002,1250.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$206,177,00028.12%
BB BIOTECH AG 8,322,860$121,763,0003.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 398,633$4,579,0002.84%
DOHENY ASSET MANAGEMENT /CA 227,193$3,324,0002.43%
SNYDER CAPITAL MANAGEMENT L P 2,833,759$41,458,0002.24%
First Light Asset Management, LLC 938,399$13,729,0002.19%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,027,164$132,067,0001.77%
Taylor Wealth Management Partners 204,277$2,989,0001.72%
Sterling Global Strategies LLC 22,000$321,860,0001.63%
Granite Investment Partners, LLC 988,939$14,468,0001.06%
View complete list of HALOZYME THERAPEUTICS INC shareholders